NALTREXONE -50MG -100CT - Multiple CMOPs - 770-25-3-801-0426
ID: 36C77025Q0114Type: Solicitation
2 AwardsJun 9, 2025
$1.7M$1,692,248
AwardeeDISABLED VETERANS HAWAII LLC Waipahu HI 96797 USA
Award #:36C77025P0195
View all 2 award notices in Lifecycle →
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/c188d1af026f43b0847a023fe3f31611/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting bids for the procurement of Naltrexone 50mg tablets, specifically for multiple Consolidated Mail Outpatient Pharmacies (CMOPs) under RFQ 36C77025Q0114. Vendors are required to submit a signed RFQ cover page, a detailed pricing schedule, proof of a valid state wholesale distributor license, and a Trade Agreements Act (TAA) certificate, ensuring compliance with stringent federal procurement standards. This procurement is critical for maintaining the supply of essential pharmaceutical products to veterans, emphasizing quality, safety, and adherence to regulatory guidelines. Interested vendors must submit their quotations to Jennifer Knight at jennifer.knight@va.gov by 4:00 PM Central Time on May 13, 2026, to be considered for this opportunity.

    Point(s) of Contact
    Jennifer L Knight
    (913) 684-0162
    jennifer.knight@va.gov
    Files
    Title
    Posted
    S02_Pre_Sol_36C77025Q0114_.pdf
    The Department of Veterans Affairs is preparing to solicit proposals for the procurement of 50mg Naltrexone tablets, packaged in 100-count bottles, for delivery to multiple Consolidated Mail Outpatient Pharmacies (CMOP) across the United States. The presolicitation notice (RFQ: 36C77025Q0114) indicates a commitment to full and open competition, allowing all responsible vendors to submit quotations by the response deadline of May 6, 2025, at 4 PM Central Time. The solicitation will include 6,360 units across various CMOP locations, specifying quantities per site. Interested vendors must comply with the Drug Supply Chain Security Act, provide their state wholesale distributor license, and submit essential documents, including a signed solicitation form, price schedule, and a Trade Agreements Act compliance certificate. The estimated issue date for the solicitation is April 29, 2025. All responses should be directed to Contract Specialist Jennifer Knight via email. This procurement underscores the VA's ongoing support for veterans' pharmaceutical needs while ensuring adherence to regulatory standards and fostering competitive bidding among suppliers.
    S02_Pricing_Schedule_Q0114_final.xlsx
    The document outlines a Request for Quotation (RFQ) under the CMOP program, specifically RFQ 36C77025Q0114, for pharmaceutical supplies with a closing date of May 13, 2026. Vendors must submit required documents including a signed SF1449 Solicitation, a comprehensive quote spreadsheet, a valid State Wholesale Distributor License, and a Trade Agreement Act (TAA) Certificate. The submission should be made to Jennifer.Knight@va.gov by 4:00 PM Central Time. The RFQ details line items listing various quantities of Naltrexone tablets required by different VA CMOP facilities across states. Each vendor is instructed to ensure that expiration dates of supplies are at least one year from delivery and to include any necessary comments, especially if proposing alternate National Drug Codes (NDCs). This solicitation reflects the federal government's stringent requirements for procurement in the healthcare sector, emphasizing compliance, quality, and accountability in the supply chain for medical supplies.
    S02_RFQ_36C77025Q0114__Final.pdf
    The document is a Request for Quotation (RFQ) issued by the Department of Veterans Affairs (VA) for the acquisition of NALTREXONE (EQV-REVIA) tablets. The solicitation outlines the requirements for vendors, including submission of a signed RFQ cover page, a detailed pricing schedule in Excel format, evidence of a valid state wholesale distributor license, and a Trade Agreements Act (TAA) certificate. The RFQ emphasizes the preference for U.S. manufactured products and mandates that all items must be bar-coded according to specified standards. Delivery terms require products to be shippable via U.S. Postal Service and shipments must reference VA obligation numbers for reconciliation. Additional stipulations include compliance with the Drug Supply Chain Security Act, specifications for packaging, and conditions regarding recalls. The contract will also incorporate various Federal Acquisition Regulation (FAR) clauses addressing contractor responsibilities, payment procedures, and conflict resolution. Overall, the RFQ aims to ensure that the VA procures pharmaceutical supplies efficiently while adhering to regulatory guidelines and prioritizing quality and safety in its supply chain.
    Similar Opportunities
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    6505--Nicotine Lozenges MINI (VA-26-00020754)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Nicotine Mini Lozenges, specifically under solicitation number 36E79726R0007. This contract aims to ensure an uninterrupted supply of nicotine lozenges for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with a contract duration of one year and four optional one-year extensions. The estimated annual requirements include 166,791 bottles of 2mg lozenges and 138,276 bottles of 4mg lozenges, which will be distributed through the VA and DOD Pharmaceutical Prime Vendor Programs. Interested offerors should note that the solicitation will be electronically issued around December 18, 2025, with a tentative closing date of January 1, 2026, and can direct inquiries to Billy Fong at billy.fong@va.gov or by phone at 708-786-4992.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for operational and mailing supplies to support seven Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. The procurement includes a wide range of items such as resealable bags, corrugated boxes, various types of mailers, child-resistant medical pouches, and packaging materials, all of which must adhere to specific material and postal regulations. This contract is crucial for ensuring the efficient operation of CMOP facilities, which play a vital role in delivering medications to veterans. Interested parties should contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov for further details, and must review the attached documents, including the pricing schedule and past performance requirements, as submissions are due by the specified deadlines.